Overview
The evidence base for GHRP-6 can span preclinical work, early human data, and—where applicable—larger clinical trials. The strength and maturity of that evidence determine how confidently clinicians and researchers talk about its effects.
Key evidence themes
- Preclinical models exploring mechanisms and proof-of-concept.
- Early human or pilot data, if available.
- Larger controlled trials for molecules with formal indications.
Context and caveats
When reviewing literature on GHRP-6, it is important to consider study design, endpoints, sample size, and duration, as well as how closely study populations match real-world use. Marketing narratives frequently move faster than rigorous evidence.
Sport & Anti-Doping Warning
GHRP-6 has been used alongside CJC-1295 in organized doping programs, including the Cronulla-Sutherland Sharks supplements saga in professional rugby league.
- >Cronulla-Sutherland Sharks supplements saga (NRL investigation)
- >Scientific work on detecting GHRP-6 and similar peptides
GHRP-6 is squarely banned under S2 and has a long history in performance-enhancing peptide stacks investigated by anti-doping authorities.